🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Shreetech raises $4.5 Mn from Aarii Ventures and Cello Family Office

EntrackrEntrackr · 3d ago
Shreetech raises $4.5 Mn from Aarii Ventures and Cello Family Office
Medial

Shreetech, a Mumbai-based digital infrastructure firm, has raised $4.5 million from Aarii Ventures, the investment arm of the Kothari family, and Cello Family Office. The proceeds will be used to expand its integrated operations across data centers, power infrastructure, and in-house equipment manufacturing. Shreetech provides end-to-end infrastructure solutions covering design, construction, technical audits, IT integration, and lifecycle management. It operates in three key verticals: data center and digital infrastructure, power infrastructure, and manufacturing of mission-critical components. It has executed more than 100 data center projects and has over 500 MW of sanctioned power capacity. Shreetech’s manufacturing unit produces core infrastructure components such as LV switchboards, smart PDUs, cable management systems, and data center ceiling systems under its Datalix line. This backward integration helps control quality, manage costs, and reduce delivery timelines. In the data center segment, Shreetech delivers turnkey projects covering civil and MEP execution, IT networks, cloud and cybersecurity integration, and smart city systems. Its power infrastructure work includes transmission lines, substations, and rail electrification. The company claims to have grown revenue from Rs 88 crore in FY21 to Rs 613 crore in FY25 at a CAGR of 62%, driven mainly by its data infrastructure business.

1

Related News

CRED raises $72 Mn from Lathe, Kunal Shah’s QED and others

EntrackrEntrackr · 2m ago
CRED raises $72 Mn from Lathe, Kunal Shah’s QED and others
Medial

CRED raises $72 Mn from Lathe, Kunal Shah’s QED and others As per Entrackr’s estimates, CRED will be valued at $3.64 billion post money, a nearly 43% haircut from its $6.4 billion valuation in the Series F round, where it raised $140 million in June 2022. Fintech unicorn CRED has received Rs 617 crore ($72 million) from multiple investors, including Lathe Investment, RTP Global, Sofina Ventures, and QED Innovation Labs, the family office of founder Kunal Shah. According to regulatory filings with the Registrar of Companies (RoC), GIC’s Lathe Investment pumped in Rs 354.4 crore ($41 million) while RTP Global and Sofina have invested Rs 74.87 crore ($8.75 million) and Rs 25.8 crore ($3 million), respectively. Kunal Shah’s family office QED Innovation Labs has infused Rs 162 crore ($19 million). As per sources, CRED will raise a total of $75 million in this round. Following the allotment of this round, GIC through Lathe Investment will hold a 5.95% stake in the firm while RTP Capital and Sofina Ventures will command 1.14% and 1.97% stakes respectively. CRED offers a range of services, including credit card management, credit score tracking, hidden charge detection, bill payment reminders, and cashback. It also provides access to shopping, travel packages, and tools for managing vehicle insurance, FASTag, and related features. While CRED is targeting full-year profitability in FY26, it reported a 22% increase in its net loss to Rs 1,644 crore in FY24. This figure includes expenses related to the employee stock ownership plan (ESOP) and taxes. During the same period, the company’s revenue surged 66% year-on-year to Rs 2,473 crore. It has yet to file its FY25 annual report.

Cambrian Bioworks raises $1.45 Mn in seed round

EntrackrEntrackr · 11m ago
Cambrian Bioworks raises $1.45 Mn in seed round
Medial

Bengaluru-based biotechnology firm Cambrian Bioworks has secured $1.45 million in its seed round led by the Irani family office, which has invested in several private ventures across the globe. The round also saw participation from the company’s CEO and co-founder, Vaibhav Hegde. The proceeds will be used to ramp up development of Cambrian’s automated molecular diagnostics platforms, R&D efforts, expand the team, and support forays into international markets. Founded by Hegde, Rohit Asil, and Raghav Sridhar, Cambrian Bioworks develops automated molecular diagnostic platforms. Its products find applications in oncology, genomics, rare disease testing, and AMR detection. Recently, the firm launched Cambrian’s nucleic acid extraction platform, Manta which provides high-quality DNA/RNA for genomics and PCR testing in hospitals and laboratories. This is yet another example of a founder investing in his own startup. This trend started with the founders of Byju’s, OYO, and BluSmart, and has recently continued with investments from the founders of Yubi and Ather Energy.

Download the medial app to read full posts, comements and news.